Literature DB >> 26242618

Authors' Reply to Cotton and Nicol's Comment on "Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia".

Woldesellassie M Bezabhe1, Luke R Bereznicki2, Leanne Chalmers2, Peter Gee2, Desalew M Kassie3, Mekides A Bimirew4, Gregory M Peterson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26242618     DOI： 10.1007/s40264-015-0335-3

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  4 in total

1.  Comment on: "Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia".

Authors:  Mark Cotton; Simone Nicol
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

2.  Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.

Authors:  Viviane D Lima; David R Bangsberg; P Richard Harrigan; Steven G Deeks; Benita Yip; Robert S Hogg; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia.

Authors:  Woldesellassie M Bezabhe; Luke R Bereznicki; Leanne Chalmers; Peter Gee; Desalew M Kassie; Mekides A Bimirew; Gregory M Peterson
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.228

4.  Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.

Authors:  Woldesellassie M Bezabhe; Leanne Chalmers; Luke R Bereznicki; Gregory M Peterson; Mekides A Bimirew; Desalew M Kassie
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.